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Case Presentation

MG is a 56-year-old female with no significant past medical
history who presented to TJUH in October 2007 with a two
year history of abdominal pain and weight loss. At presentation,
she described her pain as non-radiating, 7 out of 10, gnawing,
burning and located in the epigastrum and left upper quadrant.
The pain initially occurred approximately 15 minutes postprandially and lasted 30 minutes. Over the two year period, the
pain progressed to lasting for hours following meals. Dietary
modifications and food consistency did not help the pain. The
patient began avoiding oral intake, and her weight declined
from 120 to 80 pounds. She denied nausea, vomiting, diarrhea,
constipation, hematochezia, melena and change in stool
frequency. Over the two years prior to admission the patient
had an extensive workup with multiple gastroenterologists.
Her initial workup included a colonoscopy, EGD, abdominal
ultrasound and computerized tomography (CT) of the abdomen
and pelvis. These were all reportedly normal and the patient was
diagnosed with irritable bowel syndrome and treated symptomatically with a PPI. Due to lack of improvement, a second gastroenterologist repeated the EGD/colonoscopy and diagnosed her
with peptic ulcer disease secondary to multiple gastric ulcers.
She was treated with a PPI and carafate. A capsule study showed
gastric and jejunal ulcers with cobblestone appearance of the
small bowel which led to the diagnosis of Crohn’s disease. She
was treated briefly with Pentasa. The patient sought care as an
outpatient at TJUH Division of Gastroenterology. Mesenteric
ischemia was initially high on the differential. An MRA of the
abdomen revealed patent mesenteric vessels. Other workup
included gastric emptying scan, push enteroscopy, endoscopic
ultrasound (EUS), full-thickness biopsy in the operating room,
fasting gastrin level, and an NSAID level. These studies were
mostly inconclusive. Other studies including an octreotide scan,
gastrin levels, and chromogranin A levels were either normal
or inconclusive. Furthermore, it was discovered that the gastric
pH was 4.4, arguing against a gastrin producing tumor as seen
in Zollinger-Ellison Syndrome.
At the time of admission, her medications were pantoprazole 40
mg BID and ciprofloxacin 500 mg BID, both of which offered
only mild relief. She has a 25 pack year smoking history, does not
drink alcohol or use other drugs. Her family history is significant
for a brother and father having coronary artery disease. On
examination the patient appeared thin and pale. The abdomen
was not tender to palpation, however, an abdominal bruit could
be auscultated. Admission labs were within normal limits except
for a WBC count of 12,000 without a left shift. The question
of mesenteric ischemia was again entertained. An abdominal
ultrasound with dopplers revealed a greater than 70% stenosis of
the superior mesenteric artery (SMA). CT angiography (CTA)
of the abdomen revealed occlusion of the celiac artery, near
occlusion of the SMA, and stenosis of the inferior mesenteric
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artery (IMA). The magnetic resonance angiogram (MRA) done six
months earlier was post-processed and finally revealed stenosis of
the SMA. Vascular surgery was consulted and a decision was made
to pursue traditional angiography and stenting by interventional
radiology. Interventional radiology placed 2 overlapping stents
in the SMA which subsequently demonstrated excellent filling of
the SMA and branches. Since adequate collateral circulation was
observed, the celiac artery was not treated. The post-procedure
course was complicated by thrombosis of the left brachial artery
prompting thrombectomy. Approximately two weeks after her
procedure, the patient had no abdominal pain, is eating voraciously
and had already gained 5 pounds.

Discussion

Chronic mesenteric ischemia (CMI) can be distinguished from
acute mesenteric ischemia by the time course of the symptoms and
etiology of the disease. Acute mesenteric ischemia can be caused by
four mechanisms: SMA embolus or thrombosis, acute mesenteric
venous thrombosis, and non-occulsive mesenteric ischemia.1 The
focus of this article will be chronic mesenteric ischemia. Common
risk factors include hyperlipidemia, diabetes, and smoking.2
Although there are many possible causes of CMI, most commonly
it is secondary to atherosclerosis.2 The celiac artery (CA) and
SMA are the most commonly affected, although the IMA can be
involved. Due to the slow development of the stenosis, particularly
when atherosclerosis is the etiology, patients may develop collateral
circulation to the affected vessels. Often symptoms do not develop
until two vessels have become occluded. Symptoms commonly
include post-prandial pain beginning ~15-60 minutes after food
ingestion and last ~1-4 hours, manifest by sitophobia, weight loss,
nausea, and vomiting. Involvement of the CA distribution may
also cause gastroparesis, gastric ulceration, and even gallbladder
dyskinesia. While both physical exam and common laboratory tests
are usually unremarkable, it is common for patients to have cachexia
and stigmata of vascular disease including an abdominal bruit.2
Traditional angiography has been the gold standard for
diagnosis of CMI. Recently, however, duplex ultrasonography
(US), CTA, and MRA are increasingly used to evaluate
compromise of the mesenteric arteries. Duplex US is more
accurate in identifying SMA stenosis (90%) in comparison to
CA stenosis (80%). Areas of stenosis are identified by increases
in peak systolic or velocity of blood flow (CA>200cm/s,
SMA>275cm/s).7 Results may be affected by variations of body
habitus, bowel gas, respiration, and anatomy.2
CTA and MRA are also reliable methods for the diagnosis of
CMI.4 In the presence of a negative CTA study (particularly the
multidetector-row CTA), it is unlikely for the patient to have
CMI. MRA can identify greater than 90% of SMA lesions, 7590% of CA lesions, and 25% of IMA lesions.2 Furthermore,
some studies have reported 100% sensitivity of diagnosing

Figure 1. SMA before stent placement.
CA and SMA stenosis when compared to the gold standard of
invasive angiography.2
When two or more mesenteric vessels are occluded or
significantly stenosed in the setting of post-prandial abdominal
pain and weight loss, there are two therapeutic options. In
the past, surgical revascularization used to be the only option
available. This involved transaortic endarterectomy or antegrade
vs. retrograde bypass surgery. One study showed a 93% success
rate for endarterectomy with a high patency rate at 1 and 3
years. Unfortunately, many of the patients requiring revascularization are malnourished and at higher risk for perioperative
complications. Complication rates range from 15-33% with
mortalitiy up to 17%.3
The other therapeutic option for CMI is percutaneous angioplasty
(PCA) with or without stent placement. Unfortunately, it is
difficult to compare this modality to surgery. A study involving
25 patients revealed that clinical benefit at 11 months was 91%
and patency of the stents was 92%.5 Furthermore, the mean
complication rate for endovascular therapy is 10% with a
mortality rate up to 5%.3 Overall, it appears that endovascular
repair may have less associated morbidity and mortality,
however surgery offers the benefit of a lower re-stenosis rate.6
Finally, it should be emphasized that this case reiterates the
importance of clinical history in diagnosis. This patient’s
diagnosis was initially prolonged despite a fairly classic history,
hence CMI was not entertained. However, a false negative MRA
further delayed her diagnosis. Furthermore, the authors point
out that this patient should never have been diagnosed with
irritable bowel syndrome. The diagnosis of IBS can be made
using the Rome criteria. Weight loss is a red flag and should
have excluded this diagnosis.

Figure 2. SMA after stent placement.
While imaging and laboratory tests are generally very useful in
assisting clinicians make diagnoses, these results should never
supercede clinical acumen.

Key Points

Postprandial abdominal pain and weight loss are the typical
symptoms seen in chronic mesenteric ischemia (CMI).
1. Usually, 2 of the 3 major mesenteric vessels must be
occluded before the patient develops symptoms.
2. Diagnosis can be made by MRA, US with dopplers,
or CTA.
3. Treatment options include vascular surgery and
endovascular stenting.
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